Lee Bendekgey Insider Profile
4 Followers
Lee Bendekgey, Sr. VP CFO and General Counsel at Oruka Therapeutics, holds 6.51K shares in Oruka Therapeutics (Ticker: ORKA), holds 218.31K shares in Invitae (Ticker: NVTAQ).
Lee Bendekgey's Trading History
| NVTAQInvitae | Jul 15, 2020 | ― | Uninformative Buy | 77.55K | $2.40K | |
| ORKAOruka Therapeutics | ― | Sr. VP CFO and General Counsel | ― | $646.15K |
You May Also Like
Lee Bendekgey insider profile FAQ
What is the percentage of profitable transactions made by Lee Bendekgey?
The percentage of profitable transactions made by Lee Bendekgey is 33%.
What is the average return per transaction made by Lee Bendekgey?
The average return per transaction made by Lee Bendekgey is -91.40%.
What stocks does Lee Bendekgey hold?
Lee Bendekgey holds: ORKA, NVTAQ stocks.
What was Lee Bendekgey's most profitable transaction?
Lee Bendekgey’s most profitable transaction was an Informative Sell of NVTAQ stock on February 15, 2017. The return on the trade was 38.80%.
What is Lee Bendekgey's role in Oruka Therapeutics?
Lee Bendekgey's role in Oruka Therapeutics is Sr. VP CFO and General Counsel.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
